ZVRA
Zevra Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:26:31 PM EST
9.01USD-2.909%(-0.27)370,852
Pre-marketNov 19, 2026 9:11:30 AM EST
9.43USD+1.616%(+0.15)
Loading…
Loading…
536.43M
Healthcare
Biotechnology
HQ
Celebration, FL, USA
Previous Close
$9.28
Beta
1.03
52-Week High
$15.04 2026-07-08
52-Week Low
$8.01 2025-12-19
SMA 50
$10.80
SMA 200
$10.85
Avg. Vol 10D
1.39M
Avg. Vol 30D
967,482
Avg. Vol 90D
1.06M
Relative Vol
0.38
59.50M
53.99M
90.74%
6,556,877
12.17%
9.50
61%/39%
57.32%
41.68%
0.3500%
1,400,000
153
684
1,795
147.8M
78.0M
38.3M
60.78
41.93
Nov 18, 2026
Zevra Therapeutics to Present at the Piper Sandler Annual Healthcare Conference ·
GlobeNewswire Inc.
Nov 16, 2026
Guggenheim cuts Zevra Therapeutics price target on EU setback ·
Investing.com
Nov 13, 2026
ZVRA Profile
kempharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (nces) to treat serious medical conditions through its proprietary and broadly applicable ligand activated therapy (lat) approach. the company utilizes its lat technology to generate improved prodrug versions of fda approved drugs in the high needs areas of pain, adhd and other cns diseases.
ZVRA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 11.16 | 2026-11-12 | -19.22% | -7.645 |
| 1M | 10.16 | 2026-10-19 | -11.27% | 1.607 |
| 3M | 12.13 | 2026-08-19 | -25.68% | 1.459 |
| 6M | 10.20 | 2026-05-19 | -11.62% | 0.914 |
| 1Y | 9.68 | 2025-11-19 | -6.87% | 1.031 |
| 2Y | 8.97 | 2024-11-19 | +0.50% | — |
| 5Y | 5.33 | 2023-03-02 | +69.14% | 0.434 |
ZVRA Stock Summary
Zevra Therapeutics, Inc. Common Stock (NASDAQ:ZVRA) stock price today is $9.02, and today's volume is 369,740. ZVRA is down 2.856% today. The 30 day average volume is 967,482. ZVRA market cap is $536.43M with 59.50M shares outstanding.